Levonorgestrel enhances spermatogenesis suppression by testosterone with greater alteration in testicular gene expression in men

Biology of Reproduction

Volumn 80, Issue 3, 2009, Pages 484-492

  Lue, YanHe ^a   Wang, Christina ^a   Cui, YuGui ^b   Wang, XingHai ^b   Sha, JiaHao ^b   Zhou, ZuoMin ^b   Xu, Jun ^c   Wang, Charles ^c   Hikim, Amiya P Sinha ^a   Swerdloff, Ronald S ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b NANJING MEDICAL UNIVERSITY   (China)

^c BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

Author keywords

Male contraception; Progesterone; Spermatogenesis; Testicular gene expression; Testis; Testosterone

Indexed keywords

LEVONORGESTREL; TESTOSTERONE UNDECANOATE;

ADULT; ARTICLE; CASE REPORT; CONTRACEPTION; DNA MICROARRAY; GENE EXPRESSION; HORMONAL REGULATION; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SPERMATOGENESIS; TESTIS; TESTIS BIOPSY; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE;

ADMINISTRATION, ORAL; ADULT; BIOPSY; CONTRACEPTIVES, ORAL, SYNTHETIC; HUMANS; INHIBINS; INJECTIONS, INTRAMUSCULAR; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; LEVONORGESTREL; MALE; MIDDLE AGED; PROTEINS; SPERMATOGENESIS; STEROID 17-ALPHA-HYDROXYLASE; TESTIS; TESTOSTERONE;

EID: 62149150238     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.108.070839     Document Type: Article

References (57)

1. Wang C, Swerdloff RS. Male hormonal contraception. Am J Obstet Gynecol 2004; 190:S60-S68.
2. Bebb RA, Anawalt BD, Christensen RB, Paulsen CA, Bremner WJ, Matsumoto AM. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach. J Clin Endocrinol Metab 1996; 81:757-762.
3. Wang C, Wang XH, Nelson AL, Lee KK, Cui YG, Tong JS, Berman N, Lumbreras L, Leung A. Hull L, Desai S, Swerdloff RS. Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men. J Clin Endocrinol Metab 2006; 91:460-470.
4. Wang C, Cui YG, Wang XH, Jia Y, Sinha Hikim AP, Lue YH, Tong JS, Qian LX, Sha JH, Zhou ZM, Hull L, Leung A, et al. Transient testicular hyperthermia enhanced spermatogenesis suppression by testosterone in men. J Clin Endocrinol Metab 2007; 92:3202-3204.
5. Lue YH, Sinha Hikim AP, Wang C, Im M, Leung A, Swerdloff RS. Testicular heat exposure enhances the suppression of spermatogenesis by testosterone in rats: the "two-hit" approach to male contraceptive development. Endocrinology 2000; 141:1414-1424.
6. Lue YH, Wang C, Liu YX, Hikim AP, Zhang XS, Ng CM, Hu ZY, Li YC, Leung A, Swerdloff RS. Transient testicular warming enhances the suppressive effect of testosterone on spermatogenesis in adult cynomolgus monkeys (Macaca fascicularis). J Clin Endocrinol Metab 2006; 91:539-545.
7. O'Donnell L, Narula A, Balourdos G, Gu YQ, Wreford NG, Robertson DM, Bremner WJ, McLachlan RI. Impairment of spermatogonial development and spermiation after testosterone-induced gonadotropin suppression in adult monkeys (Macaca fascicularis). J Clin Endocrinol Metab 2001; 86:1814-1822.
8. McLachlan RI, O'Donnell L, Meachem SJ, Stanton PG, de Kretser DM, Pratis K, Robertson DM. Identification of specific sites of hormonal regulation in spermatogenesis in rats, monkeys, and man. Recent Prog Horm Res 2002; 57:149-179.
9. Ruwanpura SM, McLachlan RJ, Matthiession KL, Meachem SJ. Gonadotrophins regulate germ cell survival, not proliferation, in normal adult men. Hum Reprod 2008; 23:403-411.
10. McLachlan RI, O'Donnell L, Stanton PG, Balourdos G, Frydenberg M, de Kretser DM, Robertson DM. Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men. J Clin Endocrinol Metab 2002; 87:546-556.
11. Cui Y, Zhu H, Zhu Y, Guo X, Huo R, Wang X, Tong J, Qian L, Zhou Z, Jia Y, Lue YH, Hikim AS, et al. Proteomic analysis of testis biopsies in men treated with injectable testosterone undecanoate alone or in combination with oral levonorgestrel as potential male contraceptives. J Proteome Res 2008; 7:3984-3993.
12. Guo L, Lobenhoter EK, Wang C, Shippy R, Harris SC, Zhang L, Mei N, Chen T, Herman D, Goodsaid FM, Hurban P, Phillips KL, et al. Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat Biotechnol 2006; 24:1162-1169.
13. Lue YH, Sinha Hikim AP, Wang C, Leung A, Swerdloff RS. Functional role of inducible nitric oxide synthase in the induction of male germ cell apoptosis, regulation of sperm number, and determination of testes size: evidence from null mice. Endocrinology 2003; 144:3092-3100.
14. Bayne RA, Forster T, Burgess ST, Craigon M, Walton MJ, Baird DT, Ghazal P, Anderson RA. Molecular profiling of the human testis reveals stringent pathway-specific regulation of RNA expression following gonadotropin suppression and progestogen treatment. J Androl 2007; 29:389-403.
15. McLachlan RI, Robertson DM, Pruysers E, Ugoni A, Matsumoto AM, Anawalt BD, Bremner WJ, Meriggiola C. Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment. J Clin Endocrinol Metab 2004; 89:142-149.
16. Walton MJ, Bayne RAL, Wallace I, Baird DT, Anderson RA. Direct effect of progesterone on gene expression in the testis during gonadotropin withdrawal and early suppression of spermatogenesis. J Clin Endocrinol Metab 2006; 91:2526-2533.
17. Burkhardt E, Adham IM, Brosig B, Gastmann A, Mattei MG, Engel W. 1994 Structural organization of the porcine and human genes coding for a Leydig cell-specific insulin-like peptide (LEY I-L) and chromosomal localization of the human gene (INSL3). Genomics 1994; 20:13-19.
18. Zimmermann S, Steding G, Emmen JMA, Brinkmann AO, Nayernia K, Hiostein AF, Engel W, Adham IM. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol 1999; 13:681-691.
19. Tomboc M, Lee PA, Mitwally MF, Schneck FX, Bellinger M, Witchel SF. Insulin-like 3/Relaxin-like factor gene mutations are associated with cryptorchidism. J Clin Endocrinol Metab 2000; 85:4013-4018.
20. Amory JK, Page ST, Anawalt BD, Coviello AD, Matsumoto AM, Bremner WJ. Elevated end-of-treatment serum INSL3 is associated with failure to completely suppress spermatogenesis in men receiving male hormonal contraception. J Androl 2007; 28:548-554.
21. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 1992; 360:313-319.
22. Liu Y, Yao ZX, Bendavid C, Borgmeyer C, Han Z, Cavalli LR, Chan WY, Folmer J, Zirkin BR, Haddad BR, Gallicano 1, Rapadopoulos V. Happloinsufficiency of cytochrome P450 17α-hydroxylase/17, 20 lyase (CYP17) causes infertility in male mice. Mol Endocrinology 2005; 19: 2380-2389.
23. Liu Y, Dettin LE, Folmer J, Zirkin BR, Papadopoulos V. Abnormal morphology of spermatozoa in cytochrome P450 17α-hydoxylase/17, 20-lyase (CYP17) deficient mice. J Androl 2007; 28:453-460.
24. Sinha Hikim AP, Rajavashisth TB, Sinha Hikim I, Lue YH, Bonavera JJ, Leung A, Wang C, Swerdloff RS. Significance of apoptosis in the temporal and stage-specific loss of germ cells in the adult rat after gonadotropin deprivation. Biol Reprod 1997; 57:1193-1201.
25. Duckett CS, Nava VE, Gedrich RW, Clem RJ, Van Dongen JL, Gilfillan MC, Shiels H, Hardwick JM, Thompson CB. A conserved family of cellular genes related to the baculovirus LAP gene and encoding apoptosis inhibitors. EMBO J 1996; 15:2685-2694.
26. Guo B, Godzik A, Reed JC. Bcl-G, a novel pro-apoptotic member of the Bcl-2 family. J Biol Chem 2001; 276:2780-2785.
27. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death protease. Nature 1997; 388:300-304.
28. Soder O, Bang P, Wahab A, Parvinen M. Insulin-like growth factors selectively stimulate spermatogonial, but not meiotic, deoxyribonucleic acid synthesis during rat spermatogenesis. Endocrinology 1992; 131: 2344-2350.
29. Zhou J, Bondy C. Anatomy of the insulin-like growth factor system in the human testis. Fertil Steril 1993; 60:897-904.
30. Wang G, Hardy MP. Development of Leydig cells in the insulin-like growth factor-1 (1GF-1) knockout mouse: effects of IGF-1 replacement and gonadotropic stimulation. Biol Reprod 2004; 70:632-639.
31. Colon E, Zaman F, Axelson M, Larsson O, Carlsson-skwirut C, Svechnikov KV, Soder O. Insulin-like growth factor-1 is an important antiapoptotic factor for rat Leydig cells during postnatal development. Endocrinology 2007; 148:128-139.
32. Baxter BC. Signalling pathways involved in antiproliferative effects of IGFBP-3: a review. Mol Pathol 2001; 54:145-148.
33. Cohen P. Insulin-like growth factor binding protein-3: insulin-like growth factor independence comes of age. Endocrinology 2006; 147:2109-2111.
34. Wang D, Nagpal ML, Shimasaki S, Ling N, Lin T. Interleukin-1 induces insulin-like growth factor binding protein-3 gene expression and protein production by Leydig cells. Endocrinology 1995; 136:4049-4055.
35. Besset V, Le Magueresse-Battistoni B, Collette J, Benahmed M. Tumor necrosis factor alpha stimulates insulin-like growth factor binding protein 3 expression in cultured porcine Sertoli cells. Endocrinology 1996; 137: 296-303.
36. Butt AJ, Firth SM, King MA, Baxter RC. Insulin-like growth factorbinding protein 3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. J Biol Chem 2000; 275:39174-39181.
37. Lee K, Ma L, Yan X, Liu B, Zhang X, Cohen P. Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRa/Nur77. J Biol Chem 2005; 280: 16942-16948.
38. Feng S, Bogatcheva NV, Kamat AA, Truong A, Agoulnit AI. Endocrine effects of relaxin overexpression in mice. Endocrinology 2006; 147:407-414.
39. Samuel CS, Zhao C, Bathgate RA, Du XI, Summers RJ, Amento EP, Walker LL, McBurnie M, Zhao L, Tregear GW. The relaxin gene-knock mouse: a model of progressive fibrosis. Ann N Y Acad Sci 2005; 1041: 173-181.
40. Lok S, Johnston DS, Conklin D, Lofton-Day CE, Adams RL, Jelmberg AC, Whitmore TE, Schrader S, Griswold MD, Jaspers SR. Identification of 1NSL6, a new member of the insulin family that is expressed in the testis of the human and rat. Biol Reprod 2000; 62:1593-1599.
41. Lu C, Walker WH, Sun J, Weisz OA, Gibbs RB, Witchel SF, Sperling MA, Menon RK. Insulin-like peptide 6: characterization of secretory status and posttranslational modifications. Endocrinology 2006; 147:5611-5622.
42. Lue YH, Sinha Hikim AP, Swerdloff RS, Im P, Khay ST, Bui T, Leung A, Wang C. Single exposure to heat induces stage-specific germ cell apoptosis in rats: role of intratesticular testosterone on stage specificity. Endocrinology 1999; 40:1709-1717.
43. Tanaka SS, Toyooka Y, Akasu R, Katoh-Fukui Y, Nakahara Y, Suzuki R, Yokoyama M, Noce T. The mouse homolog of Drosophila vasa is required for the development of male germ cells. Genes Dev 2000; 14: 841-853.
44. Schrans-Stassen BH, Saunders PT, Cooke HJ, de Rooij DG. Nature of the spermatogenic arrest in Dazl-/-mice. Biol Reprod 2001; 65:771-776.
45. Tsai-Morris CH, Sheng Y, Lee E, Lei KJ, Dufau ML. Gonadotropinregulated testicular RNA helicase (GRTH/Ddx25) is essential for spermatid development and completion of spermatogenesis. Proc Natl Acad Sci U S A 2004; 101:6373-6378.
46. INK4d in human testicular germ cell tumors contrasts with high expression during normal spermatogenesis. Oncogene 2000; 19:4146-4150.
47. Zindy F, van Deursen J, Grosveld G, Sherr CJ, Roussel MF.IlNK4ddeficent mice are fertile despite testicular atrophy. Mol Cell Biol 2000; 20: 372-378.
48. INK4d. Mol Cell Biol 2001; 21:3244-3255.
49. Matsuoka S, Huang M, Elledge S. J. Linkage of ATM to cell cycle regulation by Chk2 protein kinase. Science 1998; 282:1893-1897.
50. Bartkova J, Falck J, Rajpert-De Meyts E, Skakkebek NE, Lukas J, Bartek J. Chk2 tumor suppressor protein in human spermatogenesis and testicular germ-cell tumour. Oncogene 2001; 20:5897-5902.
51. Wolgemuth DJ, Wu S. The distinct and developmentally regulated patterns of expression of members of the mouse cdc25 gene family suggest differential functions during gametogenesis. Dev Biol 1995; 170:195-206.
52. Mizoguchi S, Kim KH. Expression of cdc25 phosphatases in the germ cells of the rat testis. Bio Reprod 1997; 56:1474-1481.
53. Meng J, Holdcraft RW, Shima JE, Griswold MD, Braun RE. Androgen regulates the permeability of the blood-testis barrier. Proc Natl Acad Sci U S A 2005; 96:319-321.
54. Zitzmann M, Erren M, Kamischke A, Simoni M, Nieschlag E. Endogenous progesterone and the exogenous progestin norethisterone enanthate are associated with a proinflammatory profile in health men. J Clin Endocrinol Metab 2005; 90:6603-6608.
55. Hu J, You S, Li W, Wang D, Nagpal ML, Mi Y, Liang P, Lin T. Expression and regulation of interferon-r-inducible protein 10 gene in rat Leydig cells. Endocrinology 1998; 139:3637-3645.
56. Goffic RL, Mouchel T, Aubry F, Patard J, Ruffault A, Jegou B, Samson M. Production of the chemokines monocyte chemotactic protein-1, regulated on activation normal T cell expressed and secreted protein, growth-related oncogene, and interferon-r-inducible protein-10 is induced by the sendai virus in human and rat testicular cells. Endocrinology 2002; 143:1434-1440.
57. Nagpal ML, Chen Y, Lin T. Effects of overexpression of CXC10 (cytokine-responsive gene-2) on MA-10 mouse Leydig tumor cell steroidogenesis and proliferation. J Endocrinol 2004; 183:585-594.